Member Info for Laura2022

Had gone to 0.65p ask then the 850k

What's happening at PREM will happen here

GM and confetti and shareholder wipeout

How much does Bell get as salary ?

Thing is ..they aren't even traders as their story changes every hour....they all turned up as a pack....

George is a crook

Simple

Icecool

Just look at their posts on WG last 3weeks from JO and 5 others

Utterly despicable

Jamrock

What was telling was that it quickly went to market.order only after just a few buys

Exactly icecool

Funny watching all the elaborate theories from the U turner's

Sept 2024 results

Also encouraging has been the exploration of new ways to leverage our methodology and provide value for partners. This has been underlined by our first two licensing agreements with pharmaceutical companies, but securing further partnerships, by enhancing pharmaceutical PSPs, or incorporating resilience assessments within clinical trials, will also be a key focus for the business going forward. A key benefit for us that our methodology is condition-agnostic - whilst IBD is our initial use case, it can be utilised in management of many more chronic conditions, and we are able to adapt quickly to client specifications, and customizing programs at little-to-no additional spend, maximising the opportunity ahead of us.

Whilst no certainty can be given as to the timing or outcome from negotiations, we are in discussions with potential partners across all our commercial models, including two later-stage discussions and we look forward to updating the market as appropriate.

You to laugh at "you've gotta laugh" poster

These people are moronic

Agree Bunsen

..

Jamrock

Totally agree

Hardly ant stock 0 7p

Mentioned in results moneybags

Moving back upwards

Another account to be filtered

Your posts on WG as much of a daily U turn as JO

Don't be ridiculous Geoergr

CEO STATEMENT

The Company has made substantive progress in the commercial delivery of its resilience-based methodology so far in 2024. In its core business-to-business-to-consumer ("B2B2C") model, Trellus Health™ signed a contract and established an active collaboration with a large US health plan; whilst also working to expand the value proposition of Trellus Elevate™ into areas such as pharmaceutical patient support programs ("PSPs") and clinical trials. Our continued focus on disciplined cash management has extended our cash runway further into late Q3 2025, and we have successfully added significant experience of the US managed care industry to our Board, positioning us strongly for further commercial traction.

Finally

Totally agree

JO and then other 5 who all descended talking garbage for a week or 2

Even the one who keeps claiming "back to 50p"